Publications by authors named "M Witvrouw"

Claim this Profile
P
Preclinical profile of BI 224436, a novel HIV-1 non-catalytic-site integrase inhibitor.
Craig Fenwick, Ma'an Amad, Murray D Bailey, Richard Bethell, Michael Bös, Myriam Witvrouw

Antimicrob Agents Chemother· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short communication: Phenotypic protease inhibitor resistance and cross-resistance in the clinic from 2006 to 2008 and mutational prevalences in HIV from patients with discordant tipranavir and darunavir susceptibility phenotypes.
Richard Bethell, Joseph Scherer, Myriam Witvrouw, Agnes Paquet, Eoin Coakley

AIDS Res Hum Retroviruses· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and anti-HIV activity of novel 2,4-disubstituted-7-methyl-1,1,3-trioxo-2H,4H-pyrazolo[4,5-e][1,2,4]thiadiazine derivatives.
P Zhan, R Z Yan, X Y Liu, C Pannecouque, M Witvrouw

Drug Discov Ther· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a methylated oligoribonucleotide as a potent inhibitor of HIV-1 reverse transcription complex.
Boyan Grigorov, Anne Bocquin, Caroline Gabus, Sergey Avilov, Yves Mély, Myriam Witvrouw

Nucleic Acids Res· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-hydroxyisoquinoline-1,3(2H,4H)-diones as inhibitors of HIV-1 integrase and reverse transcriptase RNase H domain: influence of the alkylation of position 4.
Muriel Billamboz, Fabrice Bailly, Cédric Lion, Christina Calmels, Marie-Line Andréola, Myriam Witvrouw

Eur J Med Chem· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis